Hispanic Heritage and Language Influence COVID-19 Testing and Vaccination
When it comes to COVID-19 testing and vaccination, not all Hispanic populations respond the same.
"Click and Mortar" Opportunities for Digitization and Consumerism in Trials
Explore how the integration of digital tools and consumer-oriented approaches in clinical trials can enhance participant diversity and recruitment efficiency while addressing challenges in equity, ethics, and security.
The Doctor Who Wants to Change How We Treat Cardiovascular Disease
Sept. 28, 2023 — Cardiovascular disease is the number one killer of people in the United States and worldwide.
ACTIV-6 trials show no benefit to fluticasone furoate for COVID-19 symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no clinical benefit to taking fluticasone furoate for treatment of mild-to-moderate COVID-19 symptoms.
CardioHealth Alliance Study Aims to Assess How to Improve Cholesterol Management in Patients with ASCVD
CardioHealth Alliance is announcing a new project sponsored by Amgen aimed at assessing and gathering data regarding how to improve quality of care among patients hospitalized for ASCVD. This work, referred to as the “Test to Treat” project, will be led by cardiovascular disease prevention specialist and DCRI faculty member Neha Pagidipati, MD, MPH.
Study Confirms No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for 13 days for the treatment of mild-to-moderate COVID-19 symptoms.
STAR Students Complete Ninth-Annual Research Training Program
A group of promising young scientists completed the ninth annual Duke STAR Program in August, after spending the summer building research skills and working side-by-side with Duke University faculty to research medications and how they are being used.
New Blood Test Detects a Key Indicator of Parkinson’s Disease
Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.
DCRI ‘Science of Diversity’ Interns Share Lessons Learned
The first cohort of Duke Clinical Research Institute’s newest internship program, the Science of Diversity in Clinical Trials (SDCT), celebrated the conclusion of the program by presenting the importance of community engagement in clinical research, lessons learned, and their personal journeys to the program’s faculty and staff and partners in July.
Intravenous Iron Treatment Provides Some Benefit to Patients with Heart Failure and Iron Deficiency
Despite numerical improvements in mortality, hospitalizations and exercise ability, data did not reach the pre-specified level of statistical significance.